# EDGAR Filing Document

**Accession Number:** 0001939150
**File Stem:** 0001493152-25-017946
**Filing Date:** 2025-10
**Character Count:** 7486
**Document Hash:** 9e9fc982981bd24911785f35c5c231eb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-017946.hdr.sgml**: 20251014

**ACCESSION NUMBER**: 0001493152-25-017946

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20241219

**FILED AS OF DATE**: 20251014

**DATE AS OF CHANGE**: 20251014

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** GK Partners ApS
- **CENTRAL INDEX KEY:** 0001939150

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** G7
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11737
- **FILM NUMBER:** 251389966

**BUSINESS ADDRESS:**
- **STREET 1:** MESTERLODDEN 3B
- **CITY:** GENTOFTE
- **STATE:** G7
- **ZIP:** 2820
- **BUSINESS PHONE:** 45 42 90 17 33

**MAIL ADDRESS:**
- **STREET 1:** MESTERLODDEN 3B
- **CITY:** GENTOFTE
- **STATE:** G7
- **ZIP:** 2820

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Gk Partners ApS
- **DATE OF NAME CHANGE:** 20220721
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nordicus Partners Corp
- **CENTRAL INDEX KEY:** 0001011060
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 043186647
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212
- **BUSINESS PHONE:** 508-523-3141

**MAIL ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EKIMAS Corp
- **DATE OF NAME CHANGE:** 20200406

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AdvanSource Biomaterials Corp
- **DATE OF NAME CHANGE:** 20081021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIOTECH INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 19960321

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>GK Partners ApS<br><sub>(Last) (First) (Middle)</sub><br>DYREHAVEVEJ 3B<br><sub>(Street)</sub><br>KLAMPENBORG,, G7 DK-2930<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2024-12-19 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Nordicus Partners Corp [ NORD ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2024-12-19 |  | C |  | 10000 | A | $10.00 | 3359565 | D |  |
| Common Stock | 2025-01-13 |  | C |  | 1504 | A | $8.97 | 3361069 | D |  |
| Common Stock | 2025-02-03 |  | P |  | 11528 | A | $4.00 | 3372597 | D |  |
| Common Stock | 2025-02-03 |  | S |  | 54223 | D | $4.00 | 3318374 | D |  |
| Common Stock | 2025-02-03 |  | S |  | 7500 | D | $3.00 | 3310874 | D |  |
| Common Stock | 2025-02-13 |  | C |  | 11224 | A | $8.91 | 3322098 | D |  |
| Common Stock | 2025-02-19 |  | S |  | 49165 | D | $4.00 | 3272933 | D |  |
| Common Stock | 2025-04-22 |  | P |  | 10000 | A | $5.00 | 3282933 | D |  |
| Common Stock | 2025-05-02 |  | P |  | 21000 | A | $5.00 | 3303933 | D |  |
| Common Stock | 2025-05-16 |  | P |  | 12000 | A | $5.00 | 3315933 | D |  |
| Common Stock | 2025-05-22 |  | P |  | 6000 | A | $5.00 | 3321933 | D |  |
| Common Stock | 2025-05-28 |  | S |  | 109750 | D | <sup>(1)</sup> | 3212183 | D |  |
| Common Stock | 2025-05-28 |  | P |  | 113095 | A | <sup>(2)</sup> | 3325278 | D |  |
| Common Stock | 2025-05-28 |  | P |  | 49953 | D | <sup>(3)</sup> | 3275325 | D |  |
| Common Stock | 2025-06-16 |  | P |  | 7000 | A | $4.44 | 3282325 | D |  |
| Common Stock | 2025-08-08 |  | S |  | 23300 | D | $2.00 | 3259025 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Gifted in a private transaction.

(2) Gift from Nordicus Partners Corporation affiliate shareholder AC Nordic ApS.

(3) Gifted in a private transaction.

**Signature:** /s/ Tom Glaesner Larsen  
**Date:** 2025-10-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**